2013 | | A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways. | 김유석, 임혜진, 정연훈 |
2015 | | A Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and Emesis. | 박동선 |
2017 | | Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer | 강석윤, 김지훈, 노오규, 박래웅, 오영택, 윤덕용, 이현우, 전미선 |
2022 | | Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
2001 | | Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. | 김승업, 최경숙 |
2022 | | Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01) | 최진혁 |
2000 | | Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. | 김승업, 최경숙, 허균 |
2019 | | Cisplatin-Induced Ototoxicity in Rats Is Driven by RIP3-Dependent Necroptosis | 이윤영, 장정훈, 정연훈, 추옥성 |
2017 | | Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer | 노오규, 오영택, 장석준, 전미선, 조오연 |
2015 | | Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia. | 강대용 |
2006 | | Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. | 강석윤, 강승희, 김철호, 김효철, 박준성, 오영택, 이현우, 장준호, 전미선, 주희재, 최진혁, 한재호 |
2016 | | Connexin 43 Acts as a Proapoptotic Modulator in Cisplatin-Induced Auditory Cell Death | 김연주, 정연훈, 추옥성 |
2004 | | Development of Biodegradable Polymer Releasing Anticancer Drug for Intratumoral Chemotherapy of Brain Tumor-in Vitro Results | 윤수한 |
2020 | | Discovery of enhancing drugs that can prevent ototoxicity through cAMP signaling activity | 이진솔, 정연훈 |
2010 | | Efficacy of adjuvant gemcitabine-cisplatin chemotherapy: a comparative study between locally advanced transitional cell carcinoma of the bladder and upper urinary tract. | 김세중 |
2010 | | Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. | 김철호, 이진석, 정연훈 |
2016 | | Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model | 손상용 |
2017 | | FOXO3 induces ubiquitylation of AKT through MUL1 regulation | 김선용, 김철호 |
2021 | | Gap junction-mediated intercellular communication of cAMP prevents CDDP-induced ototoxicity via cAMP/PKA/CREB pathway | 김연주, 김한태, 장정훈, 정연훈 |
2016 | | Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial | 한상욱 |
2020 | | Gene regulatory network analysis with drug sensitivity reveals synergistic effects of combinatory chemotherapy in gastric cancer | 임선교 |
2014 | | Gingko biloba extracts protect auditory hair cells from cisplatin-induced ototoxicity by inhibiting perturbation of gap junctional intercellular communication | 정연훈, 최성준 |
2019 | | Growth arrest and DNA damage 45gamma is required for caspase-dependent renal tubular cell apoptosis | 신규태, 이화정 |
2017 | | Hematological parameters during concurrent chemoradiotherapy as potential prognosticators in patients with stage IIB cervical cancer | 노오규, 오영택, 유희석, 이은주, 장석준, 전미선, 조오연 |
2021 | | Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Radiologic and clinical factors predictive of survival | 권요한, 김재근, 김진우, 원제환, 조효정, 허지미 |
2022 | | Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01) | 최진혁 |
2024 | | MET overexpression in ovarian cancer via CD24-induced downregulation of miR-181a: A signalling for cellular quiescence-like state and chemoresistance in ovarian CSCs | 권지은 |
2015 | | Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04. | 최진혁 |
2014 | | Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death. | 강성운, 김철호, 신유섭 |
2016 | | Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008) | 정성현 |
2007 | | Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer. | - |
2005 | | Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. | 유희석, 이정필, 장기홍, 장혜진, 전미선 |
2014 | | Prevention of cisplatin-induced ototoxicity by the inhibition of gap junctional intercellular communication in auditory cells. | 김연주, 임혜진, 전춘걸, 정연훈 |
2012 | | Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer | 유희석, 장석준 |
2016 | | Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer | 노오규, 오영택, 장석준, 전미선, 조오연 |
2015 | | Protective effect of Artemisia asiatica (Pamp.) Nakai ex Kitam ethanol extract against cisplatin-induced apoptosis of human HaCaT keratinocytes: Involvement of NF-kappa B- and Bcl-2-controlled mitochondrial signaling. | 김연수, 김철호, 신유섭 |
2019 | | Protective Effects of Serotonin and its Derivatives, N-Feruloylserotonin and N-(p-Coumaroyl) Serotonin, Against Cisplatin-Induced Renal Damage in Mice | 양시영 |
2019 | | Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer | 최진혁 |
2006 | | Rare case of stage IA epithelial ovarian cancer with bone as the first site of recurrent metastasis. | 유희석, 이정필, 장기홍 |
2022 | | Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model | 장석준 |
2019 | | S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial | 강석윤 |
1998 | | Sensory Neural Hearing Loss after Concurrent Cisplatin and Radiation Therapy for Nasopharyngeal Carcinoma | - |
2004 | | Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. | 강승희, 김철호, 오영택, 전미선, 최진혁 |
2021 | | Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma | 조효정 |
2013 | | Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer. | 김영배, 이다근, 한재호 |
2006 | | The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis. | 강승희, 김효철, 박광주, 박준성, 신승수, 오영택, 오윤정, 이현우, 전미선, 최진혁, 황성철 |
2022 | | The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study | 장석준 |
2014 | | The Role of Connexin43 and Gap Junctional Intercellular Communication in the Apoptotic Process of Auditory Cells | 김연주, 정연훈 |
2020 | | Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01) | 최진혁 |